Bisphenol A levels in blood depend on age and exposure

Toxicology Letters

Volumn 190, Issue 1, 2009, Pages 32-40

  Mielke, Hans ^a   Gundert Remy, Ursula ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

Bisphenol A; Internal exposure; Kinetics; Newborn

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ADIPONECTIN;

ADIPOCYTE; AGE; ARTICLE; BIOACCUMULATION; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GLUCURONIDATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK ASSESSMENT; SIMULATION; SULFATION; TOXICOKINETICS;

ADULT; AGING; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; PHENOLS; PREDICTIVE VALUE OF TESTS; TISSUE DISTRIBUTION;

EID: 68349146401     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.06.861     Document Type: Article

References (67)

1. Abraham K., Mielke H., Huisinga W., and Gundert-Remy U. Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and duration. Arch. Toxicol. 79 (2005) 63-73
2. Allegaert K., Vanhole C., Vermeersch S., Rayyan M., Verbesselt R., and de Hoon J. Both postnatal and postmenstrual age contribute to the interindividual variability in tramadol glucuronidation in neonates. Early Hum. Dev. 84 (2008) 325-330
3. Alonso-Magdalena P., Morimoto S., Ripoll C., Fuentes E., and Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 114 (2006) 106-112
4. Alonso-Magdalena P., Ropero A.B., Carrera M.P., Cederroth C.R., Baquie M., Gauthier B.R., Nef S., Stefani E., and Nadal A. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS ONE 3 (2008) e2069
5. Anderson G.D. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin. Pharmacokinet. 44 (2005) 989-1008
6. Ashby J., and Odum J. Gene expression changes in the immature rat uterus: effects of uterotrophic and sub-uterotrophic doses of bisphenol A. Toxicol. Sci. 82 (2004) 458-467
7. Blair R.M., Fang H., Branham W.S., Hass B.S., Dial S.L., Moland C.L., Tong W., Shi L., Perkins R., and Sheehan D.M. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol. Sci. 54 (2000) 138-153
8. Bolger R., Wiese T.E., Ervin K., Nestich S., and Checovich W. Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ. Health Perspect. 106 (1998) 551-557
9. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., and Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ. Health Perspect. 113 (2005) 391-395
10. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., and Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ. Health Perspect. 116 (2008) 39-44
11. Campbell N.R., Van Loon J.A., and Weinshilboum R.M. Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochem. Pharmacol. 36 (1987) 1435-1446
12. Csanady G.A., Oberste-Frielinghaus H.R., Semder B., Baur C., Schneider K.T., and Filser J.G. Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein. Arch. Toxicol. 76 (2002) 299-305
13. Durando M., Kass L., Piva J., Sonnenschein C., Soto A.M., Luque E.H., and Munoz-de-Toro M. Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ. Health Perspect. 115 (2007) 80-86
14. Edginton A.N., and Ritter L. Predicting plasma concentrations of bisphenol A in young children (
15. Edginton A.N., Schmitt W., Voith B., and Willmann S. A mechanistic approach for the scaling of clearance in children. Clin. Pharmacokinet. 45 (2006) 683-704
16. European Food Safety Authority (EFSA), 2006. Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to 2,2-bis(4-hydroxyphenyl)propane; Question number EFSA-Q-2005-100, pp. 1-75. Accessed: February 1, 2009. Available at http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178620772817.htm.
17. European Union (EU), 2008. Updated European Risk Assessment Report: 4,4′-isopropylidenediphenol (bisphenol-A) (CAS Number: 80-05-7, EINECS Number: 201-245-8). Accessed: December 10, 2008. Available at: http://ecb.jrc.it/documents/Existing-chemicals/RISK_ASSESSMENT/ADDENDUM/bisphenola_add_325.pdf.
18. Filser, J.G., Csanady, G.A., Faller, T.H., 2003. Tissue burden and resulting effectiveness of bisphenol A and daidzein in humans in dependence of age. Umweltforschungsplan des Bundesministers für Umwelt, Naturschutz und Reaktorsicherheit, UBA-FB Report No. 21602001/07.
19. Fisher M.B., Paine M.F., Strelevitz T.J., and Wrighton S.A. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab. Rev. 33 (2001) 273-297
20. Fukata H., Miyagawa H., Yamazaki N., and Mori C. Comparison of ELISA- and LC-MS-based methodologies for the exposure assessment of bisphenol A. Toxicol. Mech. Methods 16 (2006) 427-430
21. Fung E.Y., Ewoldsen N.O., St Jr. G.H., Marx D.B., Miaw C.L., Siew C., Chou H.N., Gruninger S.E., and Meyer D.M. Pharmacokinetics of bisphenol A released from a dental sealant. J. Am. Dent. Assoc. 131 (2000) 51-58
22. Gow P.J., Ghabrial H., Smallwood R.A., Morgan D.J., and Ching M.S. Neonatal hepatic drug elimination. Pharmacol. Toxicol. 88 (2001) 3-15
23. Hanioka N., Naito T., and Narimatsu S. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Chemosphere 74 (2008) 33-36
24. Hodge L.S., and Tracy T.S. Alterations in drug disposition during pregnancy: implications for drug therapy. Expert Opin. Drug Metab. Toxicol. 3 (2007) 557-571
25. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., and Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 17 (2002) 2839-2841
26. Kim Y.H., Kim C.S., Park S., Han S.Y., Pyo M.Y., and Yang M. Gender differences in the levels of bisphenol A metabolites in urine. Biochem. Biophys. Res. Commun. 312 (2003) 441-448
27. Kubo K., Arai O., Ogata R., Omura M., Hori T., and Aou S. Exposure to bisphenol A during the fetal and suckling periods disrupts sexual differentiation of the locus coeruleus and of behavior in the rat. Neurosci. Lett. 304 (2001) 73-76
28. Kuester R.K., and Sipes I.G. Prediction of metabolic clearance of bisphenol A (4,4′-dihydroxy-2,2-diphenylpropane) using cryopreserved human hepatocytes. Drug Metab. Dispos. 35 (2007) 1910-1915
29. Kurebayashi H., Harada R., Stewart R.K., Numata H., and Ohno Y. Disposition of a low dose of bisphenol a in male and female cynomolgus monkeys. Toxicol. Sci. 68 (2002) 32-42
30. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., and Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300 (2008) 1303-1310
31. Lee Y.J., Ryu H.Y., Kim H.K., Min C.S., Lee J.H., Kim E., Nam B.H., Park J.H., Jung J.Y., Jang D.D., Park E.Y., Lee K.H., Ma J.Y., Won H.S., Im M.W., Leem J.H., Hong Y.C., and Yoon H.S. Maternal and fetal exposure to bisphenol A in Korea. Reprod. Toxicol. 25 (2008) 413-419
32. Mariscal-Arcas M., Rivas A., Granada A., Monteagudo C., Murcia M.A., and Olea-Serrano F. Dietary exposure assessment of pregnant women to bisphenol-A from cans and microwave containers in Southern Spain. Food Chem. Toxicol. 47 (2009) 506-510
33. Matthews J.B., Twomey K., and Zacharewski T.R. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem. Res. Toxicol. 14 (2001) 149-157
34. Miyagi S.J., and Collier A.C. Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4. Drug Metab. Dispos. 35 (2007) 1587-1592
35. Nagel S.C., vom Saal F.S., and Welshons W.V. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proc. Soc. Exp. Biol. Med. 217 (1998) 300-309
36. Negishi T., Tominaga T., Ishii Y., Kyuwa S., Hayasaka I., Kuroda Y., and Yoshikawa Y. Comparative study on toxicokinetics of bisphenol A in F344 rats, monkeys (Macaca fascicularis), and chimpanzees (Pan troglodytes). Exp. Anim. 53 (2004) 391-394
37. Nelson R.M. Textbook of Pediatrics (2002)
38. Pacifici G.M., Kubrich M., Giuliani L., de Vries M., and Rane A. Sulphation and glucuronidation of ritodrine in human foetal and adult tissues. Eur. J. Clin. Pharmacol. 44 (1993) 259-264
39. Padmanabhan V., Siefert K., Ransom S., Johnson T., Pinkerton J., Anderson L., Tao L., and Kannan K. Maternal bisphenol-A levels at delivery: a looming problem?. J. Perinatol. 28 (2008) 258-263
40. Ramsey J.C., and Andersen M.E. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73 (1984) 159-175
41. Renwick A.G. Toxicokinetics: pharmacokinetics in toxicology. In: Hayes A.W. (Ed). Principles and Methods of Toxicology (2008), Informa HealthCare 178-203
42. Sajiki J., Takahashi K., and Yonekubo J. Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 736 (1999) 255-261
43. Schönfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., and Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ. Health Perspect. 110 (2002) A703-A707
44. Sekizawa J. Low-dose effects of bisphenol A: a serious threat to human health?. J. Toxicol. Sci. 33 (2008) 389-403
45. Shimizu M., Ohta K., Matsumoto Y., Fukuoka M., Ohno Y., and Ozawa S. Sulfation of bisphenol A abolished its estrogenicity based on proliferation and gene expression in human breast cancer MCF-7 cells. Toxicol. In Vitro 16 (2002) 549-556
46. Soars M.G., Burchell B., and Riley R.J. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. J. Pharmacol. Exp. Ther. 301 (2002) 382-390
47. Sun Y., Nakashima M.N., Takahashi M., Kuroda N., and Nakashima K. Determination of bisphenol A in rat brain by microdialysis and column switching high-performance liquid chromatography with fluorescence detection. Biomed. Chromatogr. 16 (2002) 319-326
48. Takeuchi T., and Tsutsumi O. Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochem. Biophys. Res. Commun. 291 (2002) 76-78
49. Takeuchi T., Tsutsumi O., Ikezuki Y., Takai Y., and Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr. J. 51 (2004) 165-169
50. Teeguarden J.G., Waechter Jr. J.M., Clewell III H.J., Covington T.R., and Barton H.A. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol. Sci. 85 (2005) 823-838
51. Timms B.G., Howdeshell K.L., Barton L., Bradley S., Richter C.A., and vom Saal F.S. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc. Natl. Acad. Sci. USA 102 (2005) 7014-7019
52. Tominaga T., Negishi T., Hirooka H., Miyachi A., Inoue A., Hayasaka I., and Yoshikawa Y. Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC-MS/MS method. Toxicology 226 (2006) 208-217
53. Tsukioka T., Terasawa J., Sato S., Hatayama Y., Makino T., and Nakazawa H. Development of analytical method for determining trace amounts of BPA in urine samples and estimation of exposure to BPA. J. Environ. Chem. 14 (2004) 57-63
54. Tyl R.W., Myers C.B., Marr M.C., Sloan C.S., Castillo N.P., Veselica M.M., Seely J.C., Dimond S.S., Van Miller J.P., Shiotsuka R.N., Beyer D., Hentges S.G., and Waechter Jr. J.M. Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol. Sci. 104 (2008) 362-384
55. Upmeier A., Degen G.H., Diel P., Michna H., and Bolt H.M. Toxicokinetics of bisphenol A in female DA/Han rats after a single i.v. and oral administration. Arch. Toxicol. 74 (2000) 431-436
56. Völkel W., Bittner N., and Dekant W. Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. 33 (2005) 1748-1757
57. Völkel W., Colnot T., Csanady G.A., Filser J.G., and Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem. Res. Toxicol. 15 (2002) 1281-1287
58. Völkel W., Kiranoglu M., and Fromme H. Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. Toxicol. Lett. 179 (2008) 155-162
59. vom Saal F.S., Cooke P.S., Buchanan D.L., Palanza P., Thayer K.A., Nagel S.C., Parmigiani S., and Welshons W.V. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol. Ind. Health 14 (1998) 239-260
60. vom Saal F.S., and Myers J.P. Bisphenol A and risk of metabolic disorders. JAMA 300 (2008) 1353-1355
61. Welshons W.V., Nagel S.C., and vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147 (2006) S56-S69
62. Wolff M.S., Teitelbaum S.L., Windham G., Pinney S.M., Britton J.A., Chelimo C., Godbold J., Biro F., Kushi L.H., Pfeiffer C.M., and Calafat A.M. Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ. Health Perspect. 115 (2007) 116-121
63. Yamada H., Furuta I., Kato E.H., Kataoka S., Usuki Y., Kobashi G., Sata F., Kishi R., and Fujimoto S. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod. Toxicol. 16 (2002) 735-739
64. Ye X., Kuklenyik Z., Needham L.L., and Calafat A.M. Quantification of urinary conjugates of bisphenol A, 2, 5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 383 (2005) 638-644
65. Ye X., Pierik F.H., Hauser R., Duty S., Angerer J., Park M.M., Burdorf A., Hofman A., Jaddoe V.W., Mackenbach J.P., Steegers E.A., Tiemeier H., and Longnecker M.P. Urinary metabolite concentrations of organophosphorous pesticides, bisphenol A, and phthalates among pregnant women in Rotterdam, the Netherlands: the Generation R study. Environ. Res. 108 (2008) 260-267
66. Yoo S.D., Shin B.S., Kwack S.J., Lee B.M., Park K.L., Han S.Y., and Kim H.S. Pharmacokinetic disposition and tissue distribution of bisphenol A in rats after intravenous administration. J. Toxicol. Environ. Health A 61 (2000) 131-139
67. Zaya M.J., Hines R.N., and Stevens J.C. Epirubicin glucuronidation and UGT2B7 developmental expression. Drug Metab. Dispos. 34 (2006) 2097-2101